HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.49 CNY | -0.17% |
|
-6.27% | -19.59% |
Business Summary
Number of employees: 1,012
Sales per Business
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Non-steroidal Anti-inflammatory
80.7
%
| 386 | 74.9 % | 535 | 80.7 % | +38.66% |
Cardiovascular
9.5
%
| 53 | 10.4 % | 63 | 9.5 % | +17.53% |
Others
5.7
%
| 46 | 8.9 % | 38 | 5.7 % | -17.73% |
Anti-tumor
4.2
%
| 30 | 5.8 % | 28 | 4.2 % | -7.56% |
Sales per region
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
China
62.0
%
| 277 | 53.8 % | 411 | 62.0 % | +48.27% |
Overseas
38.0
%
| 238 | 46.2 % | 252 | 38.0 % | +6.04% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Ting Hao Yi
DFI | Director of Finance/CFO | 51 | 20-06-25 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ren Hui Fu
BRD | Director/Board Member | 44 | 23-04-19 |
Zhi Gang Cheng
CHM | Chairman | 50 | 20-06-25 |
Xue Qiang Huang
BRD | Director/Board Member | 57 | 20-06-25 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 288,000,000 | 70,736,394 ( 24.56 %) | 0 | 24.56 % |
Company contact information
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
122 Yangwan Road Duodao District
448000, Jingmen
+
http://www.biocause.com
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| -19.59% | 699M | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 301211 Stock
- Company Hubei Biocause Heilen Pharmaceutical Co., Ltd.
